$SGNC SANGUINE CORP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SANGUINE CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SANGUINE CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in SANGUINE CORP for free.
IRS Number: 954347608
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Trading Symbol: SGNC
Company Address: 110 FOUNDERS MILL COURT ROSWELL 30075
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
SANGUINE CORP Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 2011 | SGNC | SANGUINE CORP | Marra Frank Alan | President and CFO | Option Exercise | A | 0.20 | 3,000,000 | 600,000 | 3,000,000 | |
| Mar 21 2011 | SGNC | SANGUINE CORP | Nelson David E | Chief Financial Off ... | Grant | A | 0.00 | 7,500 | 0 | 90,833 | 83.3 K to 90.8 K (+9.00 %) |
| Mar 21 2011 | SGNC | SANGUINE CORP | Nelson David E | Chief Financial Off ... | Grant | A | 0.00 | 2,500 | 0 | 83,333 | 80.8 K to 83.3 K (+3.09 %) |
| Jun 16 2008 | SGNC | SANGUINE CORP | Nelson David E | Chief Financial Off ... | Buy | P | 0.04 | 1,000,000 | 40,000 | 1,616,794 | 616.8 K to 1.6 M (+162.13 %) |
| Apr 14 2008 | SGNC | SANGUINE CORP | Kunkel Edward L | Director | Grant | A | 0.10 | 50,000 | 5,000 | 212,500 | 162.5 K to 212.5 K (+30.77 %) |
| Apr 08 2008 | SGNC | SANGUINE CORP | Drees Thomas C | CEO | Grant | A | 0.10 | 37,500 | 3,750 | 37,015,633 | 37 M to 37 M (+0.10 %) |
| Apr 08 2008 | SGNC | SANGUINE CORP | Drees Thomas C | CEO | Grant | A | 0.11 | 25,000 | 2,750 | 36,978,133 | 37 M to 37 M (+0.07 %) |
| Apr 08 2008 | SGNC | SANGUINE CORP | Drees Thomas C | CEO | Grant | A | 0.11 | 25,000 | 2,750 | 36,953,133 | 36.9 M to 37 M (+0.07 %) |
| Apr 03 2008 | SGNC | SANGUINE CORP | Kunkel Edward L | Director | Buy | S | 0.12 | 25,000 | 3,025 | 287,500 | 262.5 K to 287.5 K (+9.52 %) |
| Apr 03 2008 | SGNC | SANGUINE CORP | Kunkel Edward L | Director | Buy | S | 0.12 | 50,000 | 6,050 | 312,500 | 262.5 K to 312.5 K (+19.05 %) |
| Apr 03 2008 | SGNC | SANGUINE CORP | Kunkel Edward L | Director | Grant | A | 0.10 | 37,500 | 3,750 | 362,500 | 325 K to 362.5 K (+11.54 %) |
| Apr 03 2008 | SGNC | SANGUINE CORP | Kunkel Edward L | Director | Grant | A | 0.11 | 25,000 | 2,750 | 325,000 | 300 K to 325 K (+8.33 %) |
| Apr 03 2008 | SGNC | SANGUINE CORP | Kunkel Edward L | Director | Grant | A | 0.11 | 25,000 | 2,750 | 300,000 | 275 K to 300 K (+9.09 %) |
| Mar 27 2008 | SGNC | SANGUINE CORP | Nelson David E | Chief Financial Off ... | Grant | A | 0.06 | 50,000 | 3,000 | 616,794 | 566.8 K to 616.8 K (+8.82 %) |
| Mar 27 2008 | SGNC | SANGUINE CORP | Nelson David E | Chief Financial Off ... | Grant | A | 0.10 | 37,500 | 3,750 | 566,794 | 529.3 K to 566.8 K (+7.08 %) |